Insider Trading activities of Agios Pharmaceuticals Inc insiders. , Part 2

Monthly summaries of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Agios Pharmaceuticals Inc since 2005 are illustrated in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Agios Pharmaceuticals Inc since year 2005. (See page 1 of this report.) Table 2 shows the detailed insider transactions of Agios Pharmaceuticals Inc since 2005. The reporting company's ticker symbol is AGIO. The reporting company's CIK number is 1439222.
The total value of stock buying since 2005 is $207,176,089.
The total value of stock sales since 2005 is $116,037,357.
The total value of stock option exercises since 2005 is $5,218,891.


 1   2 

Table 2. Detailed insider stock purchases, sales, and option exercises of Agios Pharmaceuticals Inc insiders (AGIO) , Part 2
  Trade Date   Insider Name Trade Type     Shares       Price ($)   Value ($)
2015-07-23 Goddard Glenn (Senior Vice President, Finance) Sale 7,000 120.45 843,150
2015-07-23 Goddard Glenn (Senior Vice President, Finance) Option Ex 7,000 27.37 191,590
2015-07-20 Biller Scott (Chief Scientific Officer) Sale 5,500 113.87 626,285
2015-07-20 Biller Scott (Chief Scientific Officer) Option Ex 5,500 31.64 174,020
2015-07-17 Goddard Glenn (Senior Vice President, Finance) Sale 13,000 113.71 1,478,230
2015-07-17 Goddard Glenn (Senior Vice President, Finance) Option Ex 13,000 8.79 114,322
2015-07-16 Higgons John Duncan (Chief Operating Officer) Sale 20,000 114.02 2,280,400
2015-07-16 Higgons John Duncan (Chief Operating Officer) Option Ex 20,000 .30 6,060
2015-07-16 Cantley Lewis Clayton Jr. (Director) Sale 4,852 114.19 554,025
2015-07-15 Cantley Lewis Clayton Jr. (Director) Sale 4,852 114.36 554,898
2015-06-26 Biller Scott (Chief Scientific Officer) Option Ex 7,500 .47 3,510
2015-06-25 Cantley Lewis Clayton Jr. (Director) Sale 4,852 105.66 512,662
2015-06-24 Cantley Lewis Clayton Jr. (Director) Sale 4,852 104.59 507,494
2015-06-16 Biller Scott (Chief Scientific Officer) Option Ex 300 .47 140
2015-06-15 Higgons John Duncan (Chief Operating Officer) Sale 7,000 105.23 736,610
2015-06-12 Higgons John Duncan (Chief Operating Officer) Option Ex 10,000 .30 3,030
2015-06-11 Higgons John Duncan (Chief Operating Officer) Option Ex 10,000 .30 3,030
2015-06-10 Higgons John Duncan (Chief Operating Officer) Option Ex 10,000 .30 3,030
2015-06-08 Biller Scott (Chief Scientific Officer) Sale 5,500 121.85 670,175
2015-06-01 Bowden Christopher (Chief Medical Officer) Sale 5,000 120.67 603,350
2015-06-01 Bowden Christopher (Chief Medical Officer) Option Ex 5,000 35.16 175,799
2015-06-01 Schenkein David P (Chief Executive Officer) Sale 13,000 120.67 1,568,710
2015-05-27 Goddard Glenn (Senior Vice President, Finance) Sale 2,171 120.05 260,628
2015-05-27 Goddard Glenn (Senior Vice President, Finance) Option Ex 2,171 23.10 50,150
2015-05-27 Schenkein David P (Chief Executive Officer) Sale 8,929 120.05 1,071,926
2015-05-20 Cantley Lewis Clayton Jr. (Director) Sale 4,852 116.60 565,743
2015-05-19 Cantley Lewis Clayton Jr. (Director) Sale 4,852 116.67 566,107
2015-05-15 Higgons John Duncan (Chief Operating Officer) Sale 7,417 112.89 837,305
2015-05-12 Schenkein David P (Chief Executive Officer) Sale 2,093 110.03 230,292
2015-05-11 Schenkein David P (Chief Executive Officer) Sale 3,107 110.01 341,801
2015-05-08 Schenkein David P (Chief Executive Officer) Sale 3,900 101.32 395,148
2015-05-07 Biller Scott (Chief Scientific Officer) Sale 5,500 96.32 529,760
2015-05-07 Schenkein David P (Chief Executive Officer) Option Ex 10,000 .30 3,030
2015-05-01 Schenkein David P (Chief Executive Officer) Sale 3,900 93.63 365,157
2015-04-24 Cantley Lewis Clayton Jr. (Director) Sale 4,852 106.47 516,592
2015-04-23 Cantley Lewis Clayton Jr. (Director) Sale 4,852 103.83 503,758
2015-04-15 Higgons John Duncan (Chief Operating Officer) Sale 6,583 99.54 655,271
2015-04-13 Schenkein David P (Chief Executive Officer) Sale 3,900 100.03 390,117
2015-04-08 Biller Scott (Chief Scientific Officer) Sale 5,500 97.64 537,020
2015-04-01 Schenkein David P (Chief Executive Officer) Sale 3,900 92.54 360,906
2015-03-27 Cantley Lewis Clayton Jr. (Director) Sale 4,852 96.34 467,441
2015-03-26 Cantley Lewis Clayton Jr. (Director) Sale 4,852 90.83 440,682
2015-03-16 Goddard Glenn (Senior Vice President, Finance) Sale 10,000 106.24 1,062,400
2015-03-16 Goddard Glenn (Senior Vice President, Finance) Option Ex 10,000 18.48 184,770
2015-03-16 Biller Scott (Chief Scientific Officer) Sale 5,500 106.81 587,455
2015-03-16 Biller Scott (Chief Scientific Officer) Option Ex 5,500 .47 2,574
2015-03-16 Higgons John Duncan (Chief Operating Officer) Sale 7,000 106.24 743,680
2015-03-05 Schenkein David P (Chief Executive Officer) Sale 2,600 110.16 286,416
2015-03-02 Schenkein David P (Chief Executive Officer) Sale 7,800 107.05 834,990
2015-02-27 Schenkein David P (Chief Executive Officer) Option Ex 25,000 .30 7,575
2015-02-13 Goddard Glenn (Senior Vice President, Finance) Sale 1,316 120.31 158,327
2015-02-13 Goddard Glenn (Senior Vice President, Finance) Option Ex 1,316 23.10 30,399
2015-02-13 Schenkein David P (Chief Executive Officer) Sale 684 120.31 82,292
2015-02-11 Goddard Glenn (Senior Vice President, Finance) Sale 1,513 120.14 181,771
2015-02-11 Goddard Glenn (Senior Vice President, Finance) Option Ex 1,513 23.10 34,950
2015-02-11 Schenkein David P (Chief Executive Officer) Sale 787 120.14 94,550
2015-02-09 Goddard Glenn (Senior Vice President, Finance) Sale 15,000 105.81 1,587,150
2015-02-09 Goddard Glenn (Senior Vice President, Finance) Option Ex 15,000 11.89 178,410
2015-02-02 Schenkein David P (Chief Executive Officer) Sale 10,400 114.31 1,188,824
2015-01-02 Biller Scott (Chief Scientific Officer) Sale 4,500 110.08 495,360
2015-01-02 Biller Scott (Chief Scientific Officer) Option Ex 4,500 .47 2,106
2015-01-02 Higgons John Duncan (Chief Operating Officer) Sale 24,000 110.08 2,641,920
2015-01-02 Schenkein David P (Chief Executive Officer) Sale 13,000 110.08 1,431,040
2014-12-16 Celgene European Investment Co Llc (10% Owner) Buy 228,645 110.75 25,322,433
2014-12-16 Maraganore John (Director) Buy 1,806 110.75 200,014
2014-12-01 Biller Scott (Chief Scientific Officer) Sale 4,500 97.03 436,635
2014-12-01 Biller Scott (Chief Scientific Officer) Option Ex 4,500 .47 2,106
2014-12-01 Higgons John Duncan (Chief Operating Officer) Sale 12,000 97.03 1,164,360
2014-12-01 Schenkein David P (Chief Executive Officer) Sale 13,000 97.03 1,261,390
2014-11-20 Biller Scott (Chief Scientific Officer) Option Ex 7,500 .47 3,510
2014-11-03 Goddard Glenn (Senior Vice President, Finance) Sale 2,000 81.71 163,420
2014-11-03 Goddard Glenn (Senior Vice President, Finance) Option Ex 2,000 4.87 9,738
2014-11-03 Biller Scott (Chief Scientific Officer) Sale 4,500 81.71 367,695
2014-11-03 Biller Scott (Chief Scientific Officer) Option Ex 4,500 .47 2,106
2014-11-03 Higgons John Duncan (Chief Operating Officer) Sale 13,000 81.71 1,062,230
2014-11-03 Schenkein David P (Chief Executive Officer) Sale 13,000 81.71 1,062,230
2014-10-01 Goddard Glenn (Senior Vice President, Finance) Sale 1,500 60.07 90,105
2014-10-01 Goddard Glenn (Senior Vice President, Finance) Option Ex 1,500 9.05 13,575
2014-10-01 Biller Scott (Chief Scientific Officer) Sale 4,500 60.07 270,315
2014-10-01 Biller Scott (Chief Scientific Officer) Option Ex 4,500 .47 2,106
2014-10-01 Higgons John Duncan (Chief Operating Officer) Sale 13,000 60.07 780,910
2014-10-01 Schenkein David P (Chief Executive Officer) Sale 13,000 60.07 780,910
2014-10-01 Schenkein David P (Chief Executive Officer) Option Ex 2,500 .30 757
2014-09-26 Goddard Glenn (Senior Vice President, Finance) Sale 17,500 56.53 989,275
2014-09-26 Goddard Glenn (Senior Vice President, Finance) Option Ex 17,500 4.03 70,455
2014-09-26 Schenkein David P (Chief Executive Officer) Sale 60,000 62.68 3,760,800
2014-09-26 Schenkein David P (Chief Executive Officer) Option Ex 30,000 .30 9,090
2014-09-19 Biller Scott (Chief Scientific Officer) Sale 37,996 50.45 1,916,898
2014-09-19 Biller Scott (Chief Scientific Officer) Option Ex 37,996 .47 17,782
2014-09-02 Goddard Glenn (Senior Vice President, Finance) Sale 10,000 46.30 463,000
2014-09-02 Goddard Glenn (Senior Vice President, Finance) Option Ex 10,000 1.51 15,140
2014-09-02 Biller Scott (Chief Scientific Officer) Sale 4,500 46.30 208,350
2014-09-02 Biller Scott (Chief Scientific Officer) Option Ex 4,500 .47 2,106
2014-09-02 Higgons John Duncan (Chief Operating Officer) Sale 13,000 46.30 601,900
2014-09-02 Higgons John Duncan (Chief Operating Officer) Option Ex 6,745 .30 2,043
2014-09-02 Schenkein David P (Chief Executive Officer) Sale 13,000 46.30 601,900
2014-09-02 Schenkein David P (Chief Executive Officer) Option Ex 6,500 .30 1,969
2014-08-26 Higgons John Duncan (Chief Operating Officer) Sale 5,000 45.05 225,250
2014-08-26 Higgons John Duncan (Chief Operating Officer) Option Ex 5,000 .30 1,515
2014-08-11 Schenkein David P (Chief Executive Officer) Sale 4,530 40.17 181,970
2014-08-07 Biller Scott (Chief Scientific Officer) Option Ex 5,000 .47 2,340
2014-08-01 Biller Scott (Chief Scientific Officer) Sale 4,500 39.09 175,905
2014-08-01 Biller Scott (Chief Scientific Officer) Option Ex 4,500 .47 2,106
2014-08-01 Higgons John Duncan (Chief Operating Officer) Sale 7,000 39.09 273,630
2014-08-01 Higgons John Duncan (Chief Operating Officer) Option Ex 7,000 .30 2,121
2014-08-01 Schenkein David P (Chief Executive Officer) Sale 8,470 39.17 331,769
2014-07-01 Goddard Glenn (Senior Vice President, Finance) Sale 3,500 46.52 162,820
2014-07-01 Goddard Glenn (Senior Vice President, Finance) Option Ex 3,500 1.17 4,077
2014-07-01 Biller Scott (Chief Scientific Officer) Sale 4,500 46.52 209,340
2014-07-01 Biller Scott (Chief Scientific Officer) Option Ex 4,500 .47 2,106
2014-07-01 Higgons John Duncan (Chief Operating Officer) Sale 12,000 46.52 558,240
2014-07-01 Schenkein David P (Chief Executive Officer) Sale 13,000 46.52 604,760
2014-06-23 Maraganore John (Director) Buy 2,300 43.98 101,154
2014-06-20 Biller Scott (Chief Scientific Officer) Sale 2,004 50.05 100,300
2014-06-20 Biller Scott (Chief Scientific Officer) Option Ex 2,004 .47 937
2014-06-13 Higgons John Duncan (Chief Operating Officer) Sale 5,000 45.27 226,350
2014-06-03 Higgons John Duncan (Chief Operating Officer) Sale 3,700 35.01 129,536
2014-06-02 Biller Scott (Chief Scientific Officer) Sale 4,500 33.76 151,920
2014-06-02 Biller Scott (Chief Scientific Officer) Option Ex 4,500 .47 2,106
2014-06-02 Higgons John Duncan (Chief Operating Officer) Sale 3,300 33.87 111,770
2014-05-06 Higgons John Duncan (Chief Operating Officer) Sale 5,000 45.73 228,649
2014-05-01 Goddard Glenn (Senior Vice President, Finance) Sale 2,000 42.39 84,780
2014-05-01 Goddard Glenn (Senior Vice President, Finance) Option Ex 2,000 1.17 2,330
2014-05-01 Biller Scott (Chief Scientific Officer) Sale 4,500 42.39 190,755
2014-05-01 Biller Scott (Chief Scientific Officer) Option Ex 4,500 .47 2,106
2014-05-01 Higgons John Duncan (Chief Operating Officer) Sale 7,000 42.39 296,730
2014-05-01 Higgons John Duncan (Chief Operating Officer) Option Ex 3,000 .30 909
2014-04-29 Celgene Alpine Investment Co., Llc (10% Owner) Buy 294,800 44.00 12,971,200
2014-04-29 Maraganore John (Director) Buy 2,250 44.00 99,000
2014-04-07 Goddard Glenn (Senior Vice President, Finance) Sale 2,000 45.17 90,340
2014-04-07 Goddard Glenn (Senior Vice President, Finance) Option Ex 2,000 1.51 3,028
2014-04-07 Higgons John Duncan (Chief Operating Officer) Sale 3,000 45.17 135,510
2014-04-07 Higgons John Duncan (Chief Operating Officer) Option Ex 3,000 .30 909
2014-04-01 Goddard Glenn (Senior Vice President, Finance) Sale 4,000 38.08 152,320
2014-04-01 Goddard Glenn (Senior Vice President, Finance) Option Ex 4,000 .58 2,312
2014-04-01 Biller Scott (Chief Scientific Officer) Sale 4,500 38.08 171,360
2014-04-01 Biller Scott (Chief Scientific Officer) Option Ex 34,500 .47 16,146
2014-04-01 Higgons John Duncan (Chief Operating Officer) Sale 12,000 38.08 456,960
2014-04-01 Higgons John Duncan (Chief Operating Officer) Option Ex 12,000 .30 3,636
2014-03-25 Schenkein David P (Chief Executive Officer) Option Ex 25,000 .30 7,575
2014-03-19 Higgons John Duncan (Chief Operating Officer) Option Ex 80,000 .30 24,240
2014-03-10 Higgons John Duncan (Chief Operating Officer) Option Ex 20,000 .30 6,060
2014-03-10 Schenkein David P (Chief Executive Officer) Option Ex 54,000 .30 16,362
2014-03-07 Goddard Glenn (Senior Vice President, Finance) Sale 12,000 45.10 541,200
2014-03-07 Goddard Glenn (Senior Vice President, Finance) Option Ex 12,000 .58 6,935
2014-03-07 Higgons John Duncan (Chief Operating Officer) Sale 9,000 45.10 405,900
2014-03-07 Higgons John Duncan (Chief Operating Officer) Option Ex 9,000 .30 2,727
2014-03-06 Goddard Glenn (Senior Vice President, Finance) Sale 5,468 35.54 194,332
2014-03-06 Goddard Glenn (Senior Vice President, Finance) Option Ex 5,468 .47 2,559
2014-03-06 Higgons John Duncan (Chief Operating Officer) Sale 5,646 35.54 200,658
2014-03-06 Higgons John Duncan (Chief Operating Officer) Option Ex 5,646 .30 1,710
2014-03-03 Biller Scott (Chief Scientific Officer) Sale 6,000 29.85 179,124
2014-03-03 Biller Scott (Chief Scientific Officer) Option Ex 6,000 .47 2,808
2014-03-03 Higgons John Duncan (Chief Operating Officer) Sale 8,000 29.85 238,832
2014-03-03 Higgons John Duncan (Chief Operating Officer) Option Ex 8,000 .30 2,424
2014-02-18 Goddard Glenn (Senior Vice President, Finance) Sale 3,532 35.06 123,831
2014-02-18 Goddard Glenn (Senior Vice President, Finance) Option Ex 3,532 .47 1,652
2014-02-18 Higgons John Duncan (Chief Operating Officer) Sale 2,354 35.06 82,531
2014-02-18 Higgons John Duncan (Chief Operating Officer) Option Ex 2,354 .30 713
2014-02-10 Goddard Glenn (Senior Vice President, Finance) Sale 6,000 30.44 182,640
2014-02-10 Goddard Glenn (Senior Vice President, Finance) Option Ex 6,000 .47 2,808
2014-02-03 Biller Scott (Chief Scientific Officer) Sale 6,000 25.97 155,796
2014-02-03 Biller Scott (Chief Scientific Officer) Option Ex 6,000 .47 2,808
2014-02-03 Higgons John Duncan (Chief Operating Officer) Sale 8,000 25.97 207,728
2014-02-03 Higgons John Duncan (Chief Operating Officer) Option Ex 8,000 .30 2,424
2014-01-27 Goddard Glenn (Senior Vice President, Finance) Sale 7,000 26.29 184,051
2014-01-27 Goddard Glenn (Senior Vice President, Finance) Option Ex 7,000 .47 3,276
2014-01-21 Goddard Glenn (Senior Vice President, Finance) Sale 10,000 34.71 347,110
2014-01-21 Goddard Glenn (Senior Vice President, Finance) Option Ex 10,000 .47 4,680
2014-01-21 Biller Scott (Chief Scientific Officer) Sale 6,000 34.71 208,266
2014-01-21 Biller Scott (Chief Scientific Officer) Option Ex 6,000 .47 2,808
2014-01-21 Higgons John Duncan (Chief Operating Officer) Sale 12,000 34.71 416,532
2014-01-21 Higgons John Duncan (Chief Operating Officer) Option Ex 12,000 .30 3,636
2013-07-29 Celgene Alpine Investment Co., Llc (10% Owner) Buy 708,333 18.00 12,749,994
2013-07-24 Tessier-lavigne Marc (Director) Buy 55,555 18.00 999,990
2013-07-24 Maraganore John (Director) Buy 8,333 18.00 149,994
 1   2 

Insider trading activities including stock purchases, stock sales, and option exercises of AGIO listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Agios Pharmaceuticals Inc (symbol AGIO, CIK number 1439222) see the Securities and Exchange Commission (SEC) website.